| Code | Description | Claims | Beneficiaries | Total Paid |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
67,912 |
64,592 |
$13.08M |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
53,157 |
50,260 |
$9.71M |
| 81443 |
|
6,102 |
5,714 |
$4.07M |
| 81329 |
|
34,428 |
32,409 |
$1.56M |
| 81243 |
|
47,737 |
44,994 |
$1.05M |
| 81255 |
|
25,998 |
24,425 |
$997K |
| 81251 |
|
26,165 |
24,572 |
$949K |
| 81200 |
|
22,585 |
21,156 |
$910K |
| 81401 |
|
16,104 |
15,476 |
$881K |
| 81257 |
|
27,252 |
25,618 |
$722K |
| 81412 |
|
1,473 |
1,232 |
$716K |
| 81260 |
|
22,952 |
21,510 |
$616K |
| 81330 |
|
22,490 |
21,082 |
$584K |
| 81242 |
|
22,720 |
21,282 |
$582K |
| 81290 |
|
22,708 |
21,287 |
$561K |
| 81209 |
|
22,826 |
21,362 |
$533K |
| 81205 |
|
24,282 |
22,404 |
$429K |
| 81400 |
|
22,493 |
21,088 |
$412K |
| 81250 |
|
26,182 |
24,611 |
$365K |
| 83020 |
|
26,356 |
25,302 |
$200K |
| 81479 |
Unlisted molecular pathology procedure |
19,907 |
5,145 |
$149K |
| 81361 |
|
4,838 |
4,612 |
$122K |
| 85041 |
|
32,844 |
31,650 |
$57K |
| 81162 |
|
84 |
79 |
$42K |
| 81422 |
|
1,128 |
1,052 |
$36K |
| 81408 |
|
406 |
158 |
$31K |
| 81402 |
|
1,105 |
1,029 |
$22K |
| 81407 |
|
153 |
145 |
$17K |
| 82105 |
|
1,723 |
1,667 |
$15K |
| 81298 |
|
172 |
164 |
$15K |
| 83080 |
|
2,498 |
2,363 |
$15K |
| 81201 |
|
153 |
145 |
$11K |
| 81317 |
|
168 |
160 |
$11K |
| 82677 |
|
753 |
740 |
$11K |
| 86336 |
|
1,290 |
1,248 |
$10K |
| 81292 |
|
173 |
164 |
$10K |
| 81163 |
|
151 |
144 |
$10K |
| 81406 |
|
1,469 |
158 |
$9K |
| 84702 |
|
1,292 |
1,250 |
$9K |
| 81295 |
|
174 |
164 |
$9K |
| 81321 |
|
152 |
144 |
$8K |
| 81404 |
|
294 |
164 |
$5K |
| 81405 |
|
640 |
157 |
$5K |
| 81256 |
|
452 |
390 |
$4K |
| 81332 |
|
433 |
371 |
$3K |
| 81433 |
|
55 |
38 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
39 |
30 |
$2K |
| 84163 |
|
319 |
301 |
$2K |
| 81432 |
|
56 |
39 |
$1K |
| 83021 |
|
506 |
505 |
$695.14 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
50 |
43 |
$448.75 |